Anlageziel
The Sub-Fund is actively managed and invests primarily in equity securities, and equity related securities of companies of any market capitalization. The Sub-Fund typically invests at least 80% of its net assets, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry.
Stammdaten
| Valor | A2PE7K |
| ISIN | DE000A2PE7K4 |
| Fondsgesellschaft | HANetf Management |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | USD |
| Mindestanlage | |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager | Ryan Dofflemeyer, Rafael Zayas, Austin Wen |
Aktuelle Daten
| Fondsnote | - |
| Aktueller Rücknahmepreis | 7,81 USD |
| Fonds Volumen | 11 339 995,05 USD |
| Total Expense Ratio (TER) | 0,59 % |
Gebühren
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| Rücknahmegebühr | % |
| Ausgabeaufschlag | % |
Basisdaten
| Auflagedatum | 04.04.2019 |
| Depotbank | Bank of New York Mellon SA/NV, Dublin Branch |
| Zahlstelle | |
| Domizil | Ireland |
| Geschäftsjahr | 31.03.2025 |
Performancedaten
| Veränderung Vortag | 0,02 USD |